{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34969061",
  "DateCompleted": {
    "Year": "2022",
    "Month": "01",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "12",
        "Day": "30"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e1010106",
      "10.1371/journal.ppat.1010106"
    ],
    "Journal": {
      "ISSN": "1553-7374",
      "JournalIssue": {
        "Volume": "17",
        "Issue": "12",
        "PubDate": {
          "Year": "2021",
          "Month": "Dec"
        }
      },
      "Title": "PLoS pathogens",
      "ISOAbbreviation": "PLoS Pathog"
    },
    "ArticleTitle": "Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges.",
    "Pagination": {
      "StartPage": "e1010106",
      "MedlinePgn": "e1010106"
    },
    "Abstract": {
      "AbstractText": [
        "The development of safe and effective vaccines in a record time after the emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a remarkable achievement, partly based on the experience gained from multiple viral outbreaks in the past decades. However, the Coronavirus Disease 2019 (COVID-19) crisis also revealed weaknesses in the global pandemic response and large gaps that remain in our knowledge of the biology of coronaviruses (CoVs) and influenza viruses, the 2 major respiratory viruses with pandemic potential. Here, we review current knowns and unknowns of influenza viruses and CoVs, and we highlight common research challenges they pose in 3 areas: the mechanisms of viral emergence and adaptation to humans, the physiological and molecular determinants of disease severity, and the development of control strategies. We outline multidisciplinary approaches and technological innovations that need to be harnessed in order to improve preparedeness to the next pandemic."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0001-9393-7684"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CNRS GDR2073 ResaFlu, Groupement de Recherche sur les Virus Influenza, France."
          },
          {
            "Identifier": [],
            "Affiliation": "CIRI, Centre International de Recherche en Infectiologie (Team VirPath), Inserm U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, Lyon, France."
          }
        ],
        "LastName": "Terrier",
        "ForeName": "Olivier",
        "Initials": "O"
      },
      {
        "Identifier": [
          "0000-0002-5792-7742"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CNRS GDR2073 ResaFlu, Groupement de Recherche sur les Virus Influenza, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Inserm U1100, Research Center for Respiratory Diseases (CEPR), Universit\u00e9 de Tours, Tours, France."
          }
        ],
        "LastName": "Si-Tahar",
        "ForeName": "Mustapha",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CNRS GDR2073 ResaFlu, Groupement de Recherche sur les Virus Influenza, France."
          },
          {
            "Identifier": [],
            "Affiliation": "IHAP, UMR1225, Universit\u00e9 de Toulouse, ENVT, INRAE, Toulouse, France."
          }
        ],
        "LastName": "Ducatez",
        "ForeName": "Mariette",
        "Initials": "M"
      },
      {
        "Identifier": [
          "0000-0003-3231-9027"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CNRS GDR2073 ResaFlu, Groupement de Recherche sur les Virus Influenza, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 Paris-Saclay, UVSQ, INRAE, VIM, Equipe Virus Influenza, Jouy-en-Josas, France."
          }
        ],
        "LastName": "Chevalier",
        "ForeName": "Christophe",
        "Initials": "C"
      },
      {
        "Identifier": [
          "0000-0002-0918-6804"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CNRS GDR2073 ResaFlu, Groupement de Recherche sur les Virus Influenza, France."
          },
          {
            "Identifier": [],
            "Affiliation": "CIRI, Centre International de Recherche en Infectiologie (Team VirPath), Inserm U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, Lyon, France."
          }
        ],
        "LastName": "Pizzorno",
        "ForeName": "Andr\u00e9s",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CNRS GDR2073 ResaFlu, Groupement de Recherche sur les Virus Influenza, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Universit\u00e9 Paris-Saclay, UVSQ, INRAE, VIM, Equipe Virus Influenza, Jouy-en-Josas, France."
          }
        ],
        "LastName": "Le Goffic",
        "ForeName": "Ronan",
        "Initials": "R"
      },
      {
        "Identifier": [
          "0000-0003-2663-1794"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CNRS GDR2073 ResaFlu, Groupement de Recherche sur les Virus Influenza, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Institut de Biologie Structurale (IBS), Universit\u00e9 Grenoble Alpes, CEA, CNRS, Grenoble, France."
          }
        ],
        "LastName": "Cr\u00e9pin",
        "ForeName": "Thibaut",
        "Initials": "T"
      },
      {
        "Identifier": [
          "0000-0003-1099-5075"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CNRS GDR2073 ResaFlu, Groupement de Recherche sur les Virus Influenza, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Swine Virology Immunology Unit, Ploufragan-Plouzan\u00e9-Niort Laboratory, ANSES, Ploufragan, France."
          }
        ],
        "LastName": "Simon",
        "ForeName": "Ga\u00eblle",
        "Initials": "G"
      },
      {
        "Identifier": [
          "0000-0002-0424-0277"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CNRS GDR2073 ResaFlu, Groupement de Recherche sur les Virus Influenza, France."
          },
          {
            "Identifier": [],
            "Affiliation": "RNA Biology and Influenza Virus Unit, Institut Pasteur, CNRS UMR3569, Universit\u00e9 de Paris, Paris, France."
          }
        ],
        "LastName": "Naffakh",
        "ForeName": "Nadia",
        "Initials": "N"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PLoS Pathog",
    "NlmUniqueID": "101238921",
    "ISSNLinking": "1553-7366"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Viral Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "therapy",
        "transmission",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Development"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Evolution, Molecular"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapy",
        "transmission",
        "virology"
      ],
      "DescriptorName": "Influenza, Human"
    },
    {
      "QualifierName": [
        "immunology",
        "physiology"
      ],
      "DescriptorName": "Orthomyxoviridae"
    },
    {
      "QualifierName": [
        "immunology",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Selection, Genetic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Load"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Vaccines"
    }
  ],
  "CoiStatement": "The authors have declared that no competing interests exist."
}